# Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

> **NCT00062348** · PHASE1 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 27 (estimated)

## Conditions studied

- Colorectal Cancer
- Head and Neck Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** boronophenylalanine-fructose complex
- **DRUG:** sodium borocaptate
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00062348
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062348, "Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00062348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*